As drug therapy becomes more precise and patient-specific, understanding how medicines move through the body over time is essential. Pharmacokinetics provides the scientific foundation for predicting drug concentration, optimizing dosage regimens, and ensuring therapeutic effectiveness while minimizing toxicity. Unit 4 focuses on multicompartment pharmacokinetic models, particularly the two-compartment open model, and the kinetics of multiple dosing, including steady-state concentration and dose calculations. This article presents these concepts in a simplified, news-style educational format suitable for pharmacy and life-science students.

Download UNIT 4 – Multicompartment Pharmacokinetic Models & Multiple Dosing Kinetics Notes

Get simplified revision notes for this unit:

⬇️

Download Unit 4 Notes PDF

Multicompartment Pharmacokinetic Models: Moving Beyond Simplicity

Why Multicompartment Models Are Needed

While one-compartment models assume instant and uniform drug distribution, many drugs show complex distribution patterns. Certain tissues, such as muscles, fat, or organs, take longer to equilibrate with plasma. To explain this behavior, multicompartment models are used, allowing a more realistic interpretation of drug movement within the body.

Multicompartment models divide the body into functionally distinct spaces, or compartments, based on drug distribution characteristics rather than anatomical boundaries.

Two-Compartment Open Model: A Practical Clinical Tool

Concept of the Two-Compartment Model

In the two-compartment open model, the body is divided into:

• Central compartment – includes blood and highly perfused organs such as heart, liver, and kidneys

• Peripheral compartment – includes tissues where drug distribution is slower, such as muscle and fat

After administration, the drug rapidly distributes into the central compartment, followed by a slower transfer to the peripheral compartment.

IV Bolus Administration in the Two-Compartment Model

When a drug is administered as an intravenous bolus, it enters the central compartment immediately. The plasma concentration–time curve shows two distinct phases:

1. Distribution phase (α-phase) – a rapid decline in plasma concentration due to drug movement from central to peripheral tissues

2. Elimination phase (β-phase) – a slower decline reflecting drug metabolism and excretion

This biphasic curve is a hallmark of the two-compartment open model and helps clinicians understand why plasma drug levels fall quickly initially even before elimination dominates.

Clinical Significance of the Two-Compartment Model

Understanding this model is critical for drugs such as digoxin, aminoglycosides, and certain anticancer agents. Failure to account for the distribution phase may lead to incorrect interpretation of plasma concentrations and inappropriate dosing decisions.

Kinetics of Multiple Dosing: Maintaining Therapeutic Drug Levels

Why Multiple Dosing Is Required

Many drugs have short half-lives and require repeated dosing to maintain effective plasma concentrations. Single-dose administration often fails to provide sustained therapeutic effects, making multiple dosing regimens essential in chronic therapy.

Steady-State Drug Levels: A Key Pharmacokinetic Concept

What Is Steady State?

Steady state is achieved when the rate of drug administration equals the rate of drug elimination, resulting in constant average plasma drug concentration. This typically occurs after 4–5 elimination half-lives, regardless of dose size.

At steady state, drug accumulation stabilizes, allowing predictable therapeutic outcomes.

Factors Affecting Steady State

Several factors influence the time to reach steady state:

• Drug half-life

• Dosing interval

• Clearance

• Bioavailability

Importantly, increasing the dose raises steady-state concentration but does not shorten the time to reach steady state.

Loading Dose: Achieving Rapid Therapeutic Effect

Purpose of a Loading Dose

A loading dose is a higher initial dose administered to rapidly achieve therapeutic drug levels. It is especially useful for drugs with long half-lives where waiting for steady state would delay clinical benefit.

Clinical Importance

Loading doses are commonly used in emergencies and chronic conditions requiring immediate effect, such as arrhythmias or severe infections. However, incorrect loading dose calculation may cause toxicity, emphasizing the need for pharmacokinetic precision.

Maintenance Dose: Sustaining Drug Concentration

Concept of Maintenance Dosing

A maintenance dose is the amount of drug required to maintain steady-state concentration within the therapeutic window. It replaces the amount of drug eliminated during a dosing interval.

Maintenance dosing depends on clearance, dosing frequency, and desired plasma concentration.

Clinical Significance

Proper maintenance dosing ensures long-term effectiveness without accumulation or subtherapeutic exposure. In patients with renal or hepatic impairment, dose adjustment becomes essential to avoid adverse effects.

Drug Accumulation and Fluctuation

Peak and Trough Concentrations

During multiple dosing, plasma concentrations fluctuate between:

• Peak concentration (Cmax) – highest level after dosing

• Trough concentration (Cmin) – lowest level before the next dose

Minimizing excessive fluctuation is crucial for drugs with narrow therapeutic indices.

Clinical Applications of Multiple Dosing Kinetics

Therapeutic Drug Monitoring

Understanding multiple dosing kinetics supports therapeutic drug monitoring (TDM) for drugs such as vancomycin, lithium, and phenytoin. Monitoring ensures plasma concentrations remain within safe and effective ranges.

Personalized Medicine

Pharmacokinetic principles guide individualized dosing regimens based on patient-specific factors like age, body weight, renal function, and disease state.